On behalf of the Atlas of Variant Effects (AVE) Alliance and the conference organizing committee, we are delighted to welcome you to Melbourne, Australia for the 2026 Mutational Scanning Symposium (MSS26) on 25th-27th March, 2026.

The MSS is a cornerstone event for the functional genomics community. Since its inception in 2017, we have brought together delegates from across the globe, fostering field-defining discussions and collaborations.

MSS26 will convene experts and trainees in the fields of functional genomics, protein science, precision medicine, variant interpretation, and computational genomics from around the world to meet, present their work, share expertise and provide insights into the future of this field.

The event will take place at the Aikenhead Centre for Medical Discovery (ACMD) in Melbourne, Australia. ACMD is a new centre for biomedical engineering and translational research that brings together multiple leading national universities and research institutes with a major tertiary hospital. Its unique combination of research and industry tenants means that it is uniquely positioned to tackle some of the world’s most challenging health problems, and the building has been purpose-built to foster collaborative research, with multiple floors set aside for industry partners and start-ups.

ACMD is co-located at St Vincent’s Hospital Melbourne, at the corner of Nicholson St and Victoria Parade, with fantastic access for local attendees and visiting guests both.

The event will also include selected trainee presentations and posters, a clinically-focused workshop, industry contributions and a session on the AVE Alliance. MSS26 will be an in-person event, with live-streamed plenary sessions.

Join us on social media using the hashtag #varianteffect26